Job Description

This is a high impact position with great visibility, and collaboration, across multiple departments and all levels of the Alkermes organization. This position will have critical responsibilities in the medical affairs group involved in the development of therapies for neurology and neuropsychiatric indications across late-stage programs, contributing to Alkermes’ LCM efforts in neuroscience. MD with experience in Neurology or Psychiatry requiredBoard Certification in Neurology or Psychiatry preferredA minimum of 2+ years of experience in the pharmaceutical industry in medical affairs/ clinical development or LCM functionsA business-focused individual, with experience in all aspects of drug development across late-stage clinical programsExperience interacting with global regulatory agencies, including successful sNDA submissions, label expansions and approvals is highly desiredOutstanding written and verbal communication, with experience interacting with and presenting to senior management and external audiencesAbility to navigate complexity and ambiguity in a highly matrixed work environmentDemonstrated leadership and collaborative interpersonal skills, fostering teamwork and cross-functional partnershipsSelf-motivated with the ability to work independently, prioritize tasks efficiently, and meet deadlinesDetail-oriented with expertise in conducting thorough and timely reviews of medical and trial related documents Alkermes has recently adopted a hybrid working environment to support and meet the needs of employees and this role will operate in a flexible environment with 60% of time in the office and 40% from home. This position is eligible for the hybrid workplace model, requiring work to be completed onsite at our Waltham, MA office at least 3 days per week. This role is not eligible for fully remote work.The annual base salary for this position ranges from $270,000 to $305,000. In addition, this position is eligible for an annual performance pay bonus. Exact compensation may vary based on skills, training, knowledge, and experience. Alkermes offers a competitive benefits package. Additional details can be found on our careers website: #LI-MB1Responsible for protocol design and execution across late-stage clinical research trials in neurologic disordersServe as the LCM Lead for multiple programs, including leadership of the subteams of those programsDirect authorship contributions in protocols, clinical study reports, study documents, regulatory documents, and external publicationsProvide medical oversight of clinical trial data and medical monitoring (in conjunction with a CRO medical monitoring team) of clinical trials supporting sNDA indications and LCM studiesCritically review and contribute to regulatory interactions for LCM studies, sNDAsDevelop LCM plans with cross functional teams and contribute to strategic discussions related to LCM plans and indications Develop strategy for Investigator Sponsored Studies (ISS) program with cross functional team members and serve on the ISS review committee as a reviewerResponsible for strategy and execution of product specific global expanded access and compassionate use programs in collaboration with the EAP team Represent the company to external audiences, including clinical sites, key opinion leaders, and patient advocacy groupsIn collaboration with clinical operations, oversee and coordinate the operational aspects of ongoing projects to ensure that goals of time, cost and quality performance expectation are metEnsure that standard operating procedures (SOP) for the LCM team facilitate the development of effective clinical research programs and are compliant with clinical/medical and industry standardsIdentify and develop collaborative relationships with key investigators, and key thought leaders globally. Attend, plan, and oversee lifecycle management clinical advisory boards and investigator meetings, and present at major medical conferencesFull timePosting Date: 2026-09-21

Job Tags

Similar Jobs